About Us
Verve Therapeutics was created with a singular focus: to protect the world from cardiovascular disease
Our Mission
We are striving to build the preeminent company developing gene editing medicines to treat patients with cardiovascular disease, leveraging the expertise and capabilities of our team whose singular focus is on addressing the root causes of the world’s most common cause of death. Our goal is to disrupt today’s chronic care model for treating cardiovascular disease by providing a new therapeutic approach with single-course gene editing treatments.
Verve brings together multiple breakthroughs in 21st century biomedicine — human genetic analysis, gene editing, messenger RNA (mRNA) -based therapies and lipid nanoparticle (LNP) delivery — to realize a new future of longevity and vitality for tens of millions of people around the globe with or at risk for cardiovascular disease.
Verve Team
Verve has been purpose-built for the task ahead, with a team of world-leading experts in cardiovascular medicine, human genetics, gene editing, delivery technologies, drug development and commercialization.
Our Team
Felix Acheampong, Ph.D.
Senior Scientist, Mass Spectrometry
Michael Amaonye
Senior Research Associate, Editing and Discovery
Kayla Back
Senior Research Associate, Analytics
Allison Baker, Ph.D.
Scientist, RNA Technology
Allen Barrett
Director, Corporate Counsel
Victoria Bartlett, Ph.D.
Vice President, Program and Alliance Management
Aaron Beach
Director, Analytical Development
Maggie Beaudoin
Vice President, Finance
Lisa Billings, MSc, CVT, rLAT
Associate Scientist, Preclinical Pharmacology
Souvik Biswas, Ph.D.
Director, Chemistry and Formulation
Maurine Braun
Associate Director, Toxicology
Helen Carr
Nonclinical Medical Writer
Alexandra Chadwick, Ph.D.
Associate Director, Editing and Discovery
Hareesh Chamarthi
Associate Principal Scientist, Computational Biology
Huei-Mei Chen, Ph.D.
Associate Principal Scientist, Gene Editing
Christopher J. Cheng, Ph.D.
Executive Director, RNA Technology & Manufacturing
Victoria Clendaniel
Senior Research Associate, Preclinical Pharmacology
Alexandra Cok
Manager, External Quality Control
Angela Cook
Senior Manager, Culture and Administration
Liam Cornell, Ph.D.
Senior Scientist, Editing and Discovery
James Cox
Associate Scientist, Analytical Development
Caitlin Crandall
Senior Process Development Engineer, RNA Technology & Manufacturing
Yunxiang Dai, Ph.D.
Scientist II, Mass Spectrometry
Manashree Damle
Scientist, Computational Biology
Kristopher Davis
Senior Operations Associate
Ishwin Dembla, M.S.
Senior Scientist, Analytics
Jamie DeNizio, Ph.D.
Associate Principal Scientist, Gene Editing
Joseph DePeter
Senior Engineer, Process Development
Ankur Desai
Executive Director, Analytics
Jessica Diaz
Accounts Payable Associate
Alex DiMario
Senior Manager, Supply Chain and Logistics
Emily Donlon
Associate Director, IT Applications
Andrew Dorsey
Research Associate, Formulation
Kaitlin Duffy
Senior Director, Human Resources
Chaitali Dutta, Ph.D.
Associate Director, Preclinical Pharmacology
Robin Eisner
Facilities Operations Manager
Yasser (Yas) El-Gamal, J.D.
Vice President, Legal Affairs and Chief Intellectual Property Counsel
Richard Falzone
Vice President, Clinical Operations
Anthony Federico, Ph.D.
Scientist, Bioinformatics
Greg Feinstein
Scientist, Formulation
Nicole Franaszek
Research Associate, Formulation
Nancy Fuselli, BSc, RAC
Executive Director, Quality Assurance
Jack Ganey
Associate Scientist, Editing and Discovery
Soumya Gangopadhyay, Ph.D.
Associate Principal Scientist, Bioanalysis
Sara Garcia, Ph.D.
Associate Principal Scientist, Computational Biology
Ryan Garrity
Associate Scientist, Preclinical Pharmacology
Kevin Gichuru
Senior Manager, Accounting
Michael Gilman
Associate Principal Engineer, Process Development
Zachary Glass, Ph.D.
Scientist, Formulation
Kasey Goon
Associate Scientist, Bioanalysis
Matthew Greenfield
Associate Director, Laboratory Operations
Peter Hallock, Ph.D.
Director, Editing and Discovery
Christina Hao, Ph.D.
Senior Scientist, Next Generation Sequencing
Erin Hood
Senior Contracts Specialist
Yanlin Huang
Payroll Manager
Ivan Ivanov
Scientist II, Editor Development
Sowmya Iyer, Ph.D.
Associate Director, Computational Biology and Genome Sciences
Paris James
Research Associate, RNA Technology
Hari Jayaram, Ph.D.
Vice President, Editing and Discovery
Chelsey Jensen
Director, Clinical Operations
Yang Jiao, Ph.D.
Senior Scientist, Editing and Discovery
Christopher Johnson
Manager, External Quality Control
Lisa Kasiewicz, Ph.D.
Senior Scientist, Formulations
Amit Khera, M.D.
Executive Director, Genomic Medicine
Jaime Kirk
Controller
Sunita Kumar
Associate Director, Quality Assurance
Jeong-Ah Kwon
Scientist II, Analytics
Nick Laschkewitsch
Research Associate, Process Development
Jennifer Lavoie
Director, CMC Project Management
Seka Lazare, Ph.D.
Associate Director, Next Generation Sequencing
Anson Le
Research Associate, Analytics
Jay Lee
Associate Director, Financial Planning and Analysis
Richard Lee, Ph.D.
Senior Director, Preclinical Pharmacology and Translational Medicine
Jay Leipheimer
Scientist, RNA Technology
Amy Li
Clinical Trial Specialist
Jeffrey Li
Associate Scientist, Editing and Discovery
Bryan MacDonald, Ph.D.
Director, Pharmacology and Toxicology
James Madsen, Ph.D.
Director, Mass Spectrometry
Padma Malyala
Vice President, Formulation and Analytical Development
Jessica Mangano
Senior Engineer, Process Development
Yuri Matsumoto, Ph.D.
Associate Director, Bioanalysis
Anne Marie Mazzola
Study Manager, Preclinical Pharmacology and Toxicology
Lisa McCurley
Director, Regulatory Operations
Emma Mei
Senior Accountant
Kim Milliken
Senior Director, Regulatory CMC
Harlisa Minaya
Senior Human Resources Generalist
Lauren Mineo
Executive Assistant, Research and Development
Taiji Mizoguchi, Ph.D.
Associate Principal Scientist, Preclinical Pharmacology
Jeffrey Molles
Senior Director, Clinical Data Management
Danielle Montt
In Vivo Study Coordinator
Kate Morneault
Senior Manager, SEC Reporting and Technical Accounting
Sagar Mudshinge, Ph.D.
Scientist, Discovery Chemistry
Maria Murray
Receptionist and Administrative Office Associate
Ash Nagpal
Associate Principal Engineer, Formulation
Robyn Naigles
Human Resources Specialist
Namrata Nammi
Scientist, Analytics
Yusuf Nasrullah
Scientist, Editing and Discovery
April O'Neil
Associate Director, Human Resources
Alline Pacheco, Ph.D.
Senior Scientist, Editing and Discovery
Johnathan Petit
External Quality Assurance Associate
Colin Platt, Ph.D.
Scientist, Bioanalysis
Brent V. Powell, Ph.D.
Scientist II, Analytics
Hoda Rajabi
Scientist, Next Generation Sequencing
Kallanthottathil G. Rajeev, Ph.D.
Vice President, CMC
Caroline Reiss, Ph.D.
Senior Scientist, RNA Technology
Huilan Ren
Scientist, Formulation
Jennifer Robinson
Vice President, Investor Relations and Corporate Communications
Ellen Rohde, Ph.D.
Vice President, Preclinical Pharmacology and Toxicology
Leocadia Ruiz
Director, External Quality Control
Chloe Salisbury
Quality Assurance Associate
Ivan Sandler
Associate Director, External Manufacturing
Athul Sanjeev
Senior Research Associate, RNA Technology
Ryan Santos
Research Associate, Editing and Discovery
Matthew Schmidt, Pharm.D.
Director, Regulatory Affairs
Derek Sethachutkul
Senior Director, External Manufacturing
Estela Shabani, Ph.D.
Scientist II, Editing and Discovery
Wynn Shatzer
Senior Research Associate, Analytics
Jax Shay
Senior Research Associate, Analytics
Andrew Sheely
Executive Director, Information Technology
Leya Siddiqui
Research Associate, Analytics
Vanessa Smiley
Manager, External Quality Assurance
Luke Spence
Senior Manager, IT Operations
Dhinesh Kannan Srinivasan Kamalakkannan
Research Associate, Bioanalysis
Mary Stahley, Ph.D.
Director, Process Development
Mila Stanojevic
Research Associate, Analytics
Nikolas Steege
Research Associate, Analytics
Casey Stevens, Ph.D.
Scientist II, Process Development
Ryan Stoeckel
Associate Director, Procurement
Leslie Stolz, Ph.D.
Vice President, Regulatory Affairs
Lynnsey Street
Associate Scientist, Process Development
Vidya Subramanian, Ph.D.
Associate Director, Discovery Technology Development
Eric Tillotson
Senior Engineer, Process Development
Scott Vafai, M.D.
Vice President, Translational Medicine
Kui Wang, Ph.D.
Associate Principal Scientist, RNA Technology
Carina Nyberg Washington
Executive Assistant
Meghan Weinreb
Associate Director, Internal Quality Assurance
Chris Welch
Director, External Manufacturing
Francis Wong
Associate Scientist, Editing and Discovery
Nolan Yu
Senior Director, Financial Planning & Analysis
Leadership
Andrew Ashe, J.D.
President and Chief Operating Officer
Andrew Bellinger, M.D., Ph.D.
Chief Scientific Officer and Chief Medical Officer
Allison Dorval
Chief Financial Officer
Sekar Kathiresan, M.D.
Co-Founder, Chief Executive Officer and Board Member
Joan Nickerson
Senior Vice President, Human Resources and Facilities
Jason Politi
Senior Vice President, Technical Operations
Founders
Burt Adelman, M.D.
Co-Founder and Chairman of the Board
J. Keith Joung, M.D., Ph.D.
Co-Founder
Sekar Kathiresan, M.D.
Co-Founder, Chief Executive Officer and Board Member
Kiran Musunuru, M.D., Ph.D., MPH
Co-Founder and Senior Scientific Advisor
Anthony Philippakis, M.D., Ph.D.
Co-Founder and Scientific Advisory Board Member
Issi Rozen, MBA
Co-Founder and Strategic Advisor
Barry Ticho, M.D., Ph.D.
Co-Founder
Scientific Advisory Board
Eugene Braunwald, M.D.
Scientific Advisory Board Member
Andrew Geall, Ph.D.
Scientific Advisory Board Member
Penny M. Heaton, M.D.
Scientific Advisory Board Member
Kiran Musunuru, M.D., Ph.D., MPH
Co-Founder and Senior Scientific Advisor
Anthony Philippakis, M.D., Ph.D.
Co-Founder and Scientific Advisory Board Member
Daniel J. Rader, M.D.
Scientific Advisory Board Member
Collaborations and Licensing
Verve has in-licensed a portfolio of gene editing and delivery technologies through strategic collaborations and licensing agreements with industry leaders, including Beam Therapeutics, the Broad Institute, Harvard University and Acuitas Therapeutics, Inc.
Through independent development of our capabilities and new technologies, Verve has established deep expertise in the research and development of gene editing medicines. We seek out and are open to exploring additional opportunities where these capabilities and our expertise can be applied to new strategic collaborations and programs.
To inquire about such opportunities, please fill out this form →